a total of 109 patients with advanced lung cancer , all cell types , were randomized between macc chemotherapy only , consisting of methotrexate , doxorubicin ( adriamycin ) , cyclophosphamide , and lomustine ( ccnu ) ;
C0065473
macc
C0010583
cyclophosphamide